Pharmaceutical formulations
US6730679B1 · kind B1 · utility
5Cited by
7References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 1997 |
| Grant date | May 4, 2004 |
| Priority date | — |
| Expiry date | Nov 11, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/635
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical formulations containing HIV protease inhibitors, specifically including 3S-[3R*(1R*,2S*)]-[3-[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic acid, tetrahydro-3-furanyl ester (alternatively known as VX 478 or 141W94), and a tocopherol, and their use in medical therapy are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.